Form 4: Bausch Health Director Brett Icahn Acquires Shares in Lieu of Cash Compensation
SEC Form 4 Filing
Director Brett Icahn acquired 5,119 common shares of Bausch Health Companies Inc. in lieu of cash compensation for board service.
Summary
- On March 31, 2025, Brett Icahn, a director of Bausch Health Companies Inc., acquired 5,119 common shares of the company.
- The shares were received in lieu of cash compensation for his service on the Issuer's Board of Directors for the quarter ending March 31, 2025.
- The price of the shares was $6.47.
- Following the transaction, Icahn directly owns 161,899 common shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction of a director receiving shares as compensation. It doesn't indicate any major positive or negative development for the company.
Positives
- A director taking shares in lieu of cash compensation can be seen as a positive sign of confidence in the company's future.
Industry Context
Directors receiving stock in lieu of cash compensation is a fairly common practice, especially for board members. It aligns their interests with those of shareholders.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of transaction: Brett Icahn acquired shares in lieu of cash compensation. |
| 03/31/2025 | End of quarter for which the shares were issued as compensation. |
| 04/01/2025 | Date of signature on the Form 4 filing. |
Keywords
Bausch Health, Brett Icahn, Director, Share Acquisition, Form 4, Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.